207 related articles for article (PubMed ID: 26241898)
1. Tumor Progression Locus 2 Promotes Induction of IFNλ, Interferon Stimulated Genes and Antigen-Specific CD8+ T Cell Responses and Protects against Influenza Virus.
Kuriakose T; Tripp RA; Watford WT
PLoS Pathog; 2015 Aug; 11(8):e1005038. PubMed ID: 26241898
[TBL] [Abstract][Full Text] [Related]
2. Tpl2 kinase regulates T cell interferon-gamma production and host resistance to Toxoplasma gondii.
Watford WT; Hissong BD; Durant LR; Yamane H; Muul LM; Kanno Y; Tato CM; Ramos HL; Berger AE; Mielke L; Pesu M; Solomon B; Frucht DM; Paul WE; Sher A; Jankovic D; Tsichlis PN; O'Shea JJ
J Exp Med; 2008 Nov; 205(12):2803-12. PubMed ID: 19001140
[TBL] [Abstract][Full Text] [Related]
3. Tpl2 Ablation Leads to Hypercytokinemia and Excessive Cellular Infiltration to the Lungs During Late Stages of Influenza Infection.
Latha K; Jamison KF; Watford WT
Front Immunol; 2021; 12():738490. PubMed ID: 34691044
[TBL] [Abstract][Full Text] [Related]
4. Pharmacological inhibition of TPL2/MAP3K8 blocks human cytotoxic T lymphocyte effector functions.
Chowdhury FZ; Estrada LD; Murray S; Forman J; Farrar JD
PLoS One; 2014; 9(3):e92187. PubMed ID: 24642963
[TBL] [Abstract][Full Text] [Related]
5. Tumor Progression Locus 2 (Tpl2) Activates the Mammalian Target of Rapamycin (mTOR) Pathway, Inhibits Forkhead Box P3 (FoxP3) Expression, and Limits Regulatory T Cell (Treg) Immunosuppressive Functions.
Li X; Acuff NV; Peeks AR; Kirkland R; Wyatt KD; Nagy T; Watford WT
J Biol Chem; 2016 Aug; 291(32):16802-15. PubMed ID: 27261457
[TBL] [Abstract][Full Text] [Related]
6. Tumor progression locus 2 (Map3k8) is critical for host defense against Listeria monocytogenes and IL-1 beta production.
Mielke LA; Elkins KL; Wei L; Starr R; Tsichlis PN; O'Shea JJ; Watford WT
J Immunol; 2009 Dec; 183(12):7984-93. PubMed ID: 19933865
[TBL] [Abstract][Full Text] [Related]
7. Foot-and-Mouth Disease Virus Capsid Protein VP1 Antagonizes TPL2-Mediated Activation of the IRF3/IFN-β Signaling Pathway to Facilitate the Virus Replication.
Hao J; Shen C; Wei N; Yan M; Zhang X; Xu G; Zhang D; Hou J; Cao W; Jin Y; Zhang K; Zheng H; Liu X
Front Immunol; 2020; 11():580334. PubMed ID: 33488582
[TBL] [Abstract][Full Text] [Related]
8. Influenza-induced Tpl2 expression within alveolar epithelial cells is dispensable for host viral control and anti-viral immunity.
Wyatt KD; Sarr D; Sakamoto K; Watford WT
PLoS One; 2022; 17(1):e0262832. PubMed ID: 35051238
[TBL] [Abstract][Full Text] [Related]
9. The Influenza-Induced Pulmonary Inflammatory Exudate in Susceptible Tpl2-Deficient Mice Is Dictated by Type I IFN Signaling.
Latha K; Patel Y; Rao S; Watford WT
Inflammation; 2023 Feb; 46(1):322-341. PubMed ID: 36227523
[TBL] [Abstract][Full Text] [Related]
10. Tpl2 Promotes Innate Cell Recruitment and Effector T Cell Differentiation To Limit Citrobacter rodentium Burden and Dissemination.
Acuff NV; Li X; Latha K; Nagy T; Watford WT
Infect Immun; 2017 Oct; 85(10):. PubMed ID: 28760932
[TBL] [Abstract][Full Text] [Related]
11. Nucleotide oligomerization and binding domain 2-dependent dendritic cell activation is necessary for innate immunity and optimal CD8+ T Cell responses to influenza A virus infection.
Lupfer C; Thomas PG; Kanneganti TD
J Virol; 2014 Aug; 88(16):8946-55. PubMed ID: 24872587
[TBL] [Abstract][Full Text] [Related]
12. Deficiency of the NOD-Like Receptor NLRC5 Results in Decreased CD8
Lupfer CR; Stokes KL; Kuriakose T; Kanneganti TD
J Virol; 2017 Sep; 91(17):. PubMed ID: 28615208
[TBL] [Abstract][Full Text] [Related]
13. Tumor progression locus 2 differentially regulates IFNγ and IL-17 production by effector CD4+ T cells in a T cell transfer model of colitis.
Acuff NV; Li X; Kirkland R; Nagy T; Watford WT
PLoS One; 2015; 10(3):e0119885. PubMed ID: 25781948
[TBL] [Abstract][Full Text] [Related]
14. Tumor progression locus 2 (Tpl2) kinase promotes chemokine receptor expression and macrophage migration during acute inflammation.
Rowley SM; Kuriakose T; Dockery LM; Tran-Nguyen T; Gingerich AD; Wei L; Watford WT
J Biol Chem; 2014 May; 289(22):15788-97. PubMed ID: 24713702
[TBL] [Abstract][Full Text] [Related]
15. TPL2 Kinase Is a Crucial Signaling Factor and Mediator of NKT Effector Cytokine Expression in Immune-Mediated Liver Injury.
Vyrla D; Nikolaidis G; Oakley F; Perugorria MJ; Tsichlis PN; Mann DA; Eliopoulos AG
J Immunol; 2016 May; 196(10):4298-310. PubMed ID: 27053764
[TBL] [Abstract][Full Text] [Related]
16. Tpl2 promotes neutrophil trafficking, oxidative burst, and bacterial killing.
Acuff NV; Li X; Elmore J; Rada B; Watford WT
J Leukoc Biol; 2017 Jun; 101(6):1325-1333. PubMed ID: 28356348
[TBL] [Abstract][Full Text] [Related]
17. Tumor Progression Locus 2 Protects against Acute Respiratory Distress Syndrome in Influenza A Virus-Infected Mice.
Latha K; Rao S; Sakamoto K; Watford WT
Microbiol Spectr; 2022 Oct; 10(5):e0113622. PubMed ID: 35980186
[TBL] [Abstract][Full Text] [Related]
18. Type I IFN signaling facilitates the development of IL-10-producing effector CD8
Jiang L; Yao S; Huang S; Wright J; Braciale TJ; Sun J
Eur J Immunol; 2016 Dec; 46(12):2778-2788. PubMed ID: 27701741
[TBL] [Abstract][Full Text] [Related]
19. Casein Kinase 1α Mediates the Degradation of Receptors for Type I and Type II Interferons Caused by Hemagglutinin of Influenza A Virus.
Xia C; Wolf JJ; Vijayan M; Studstill CJ; Ma W; Hahm B
J Virol; 2018 Apr; 92(7):. PubMed ID: 29343571
[TBL] [Abstract][Full Text] [Related]
20. Tpl2 and ERK transduce antiproliferative T cell receptor signals and inhibit transformation of chronically stimulated T cells.
Tsatsanis C; Vaporidi K; Zacharioudaki V; Androulidaki A; Sykulev Y; Margioris AN; Tsichlis PN
Proc Natl Acad Sci U S A; 2008 Feb; 105(8):2987-92. PubMed ID: 18287049
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
